We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+33.77%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$1.12B
AUM Growth
+$82.1M
(+7.9%)
Cap. Flow
+$59.9M
Cap. Flow
% of AUM
5.37%
Top 10 Holdings %
Top 10 Hldgs %
76.06%
Holding
154
New
47
Increased
20
Reduced
41
Closed
36
Top Buys
| 1 |
HNP
Huaneng Power Intl, Inc.
HNP
|
+$38M |
| 2 |
TELL
Tellurian Inc.
TELL
|
+$7.01M |
| 3 |
Senseonics Holdings Inc
SENS
|
+$5.91M |
| 4 |
International Money Express
IMXI
|
+$3.99M |
| 5 |
Vericel Corp
VCEL
|
+$3.04M |
Top Sells
| 1 |
Dine Brands
DIN
|
+$3.87M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$3.15M |
| 3 |
Wabash National
WNC
|
+$2.8M |
| 4 |
NetEase
NTES
|
+$2.32M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$2.28M |
Sector Composition
| 1 | Healthcare | 5.42% |
| 2 | Consumer Discretionary | 2.8% |
| 3 | Technology | 2.75% |
| 4 | Communication Services | 1.7% |
| 5 | Energy | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.4B
| $182M | 16.31% |
+750,000
| New | +$184M |
|
2
PUT
iShares Russell 2000 ETF
IWM
$82.6B
| $142M | 12.68% |
864,400
+614,400
| +246% | +$98.3M |
|
3
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.4B
| $106M | 9.52% |
+1,970,000
| New | +$91.2M |
|
|
4
CALL
iShares Russell 2000 ETF
IWM
$82.6B
| $98.3M | 8.8% |
600,000
-400,000
| -40% | -$64M |
|
5
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
| $85.1M | 7.62% |
1,000,000
+900,000
| +900% | +$77.1M |
|
6
PUT
Invesco QQQ Trust
QQQ
$473B
| $77.2M | 6.92% |
450,000
-115,000
| -20% | -$19.3M |
|
7
CALL
JPMorgan Chase
JPM
$912B
| $52.1M | 4.67% |
+500,000
| New | +$54.8M |
|
8
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $46.1M | 4.13% |
170,000
+40,000
| +31% | +$10.8M |
|
9
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $36.6M | 3.28% |
+385,000
| New | +$35.4M |
|
10
CALL
Morgan Stanley
MS
$343B
| $23.7M | 2.12% |
+500,000
| New | +$26.1M |
|
11
CALL
iShares China Large-Cap ETF
FXI
$4.66B
| $22.2M | 1.99% |
+900,000
| New | +$42.1M |
|
|
MRNS
12
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $18.7M | 1.67% |
659,580
| – | – |
|
13
CALL
Apple
AAPL
$4.89T
| $14.8M | 1.33% |
320,000
-380,000
| -54% | -$17.2M |
|
14
CALL
Vertex Pharmaceuticals
VRTX
$123B
| $10.2M | 0.91% |
+60,000
| New | +$9.3M |
|
15
Axogen
AXGN
$2.12B
| $8.99M | 0.81% |
178,951
-13,800
| -7% | -$608K |
|
|
CELG
16
CALL
DELISTED
Celgene Corp
CELG
| $7.94M | 0.71% |
+100,000
| New | +$8.3M |
|
|
17
Senseonics Holdings Inc
SENS
$268M
| $6.78M | 0.61% |
+82,500
| New | +$5.91M |
|
|
TELL
18
DELISTED
Tellurian Inc.
TELL
| $6.43M | 0.58% |
773,100
+702,100
| +989% | +$7.01M |
|
|
GOOS
19
Canada Goose Holdings
GOOS
$970M
| $6.11M | 0.55% |
103,800
-35,000
| -25% | -$1.47M |
|
20
Golar LNG
GLNG
$5.06B
| $5.78M | 0.52% |
196,200
+79,400
| +68% | +$2.41M |
|
21
Meta Platforms (Facebook)
META
$1.69T
| $5.57M | 0.5% |
28,650
-11,800
| -29% | -$2.13M |
|
22
Lumentum
LITE
$54.9B
| $5.3M | 0.48% |
91,600
+18,700
| +26% | +$1.11M |
|
|
ADMS
23
DELISTED
Adamas Pharmaceuticals
ADMS
| $5.22M | 0.47% |
202,115
-40,800
| -17% | -$1.13M |
|
|
24
CALL
Invesco QQQ Trust
QQQ
$473B
| $5.15M | 0.46% |
30,000
-1,295,000
| -98% | -$217M |
|
25
Tandem Diabetes Care
TNDM
$1.12B
| $4.96M | 0.44% |
+225,000
| New | +$2.77M |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Granite Point Capital Management held 154 positions worth $1.12B, up 7.9% from $1.03B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Granite Point Capital Management deployed $59.9M of net new capital in Q2 2018, opening 47 new positions and adding to 20 existing holdings. Its largest new stake was Huaneng Power Intl, Inc.: 1,400,000 shares worth $928K.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.5% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was GW Pharmaceuticals Plc American Depositary Shares, an estimated $3.15M trimmed.
- Granite Point Capital Management's largest Q2 2018 buy was Huaneng Power Intl, Inc.: 1,400,000 shares worth $928K.
- Granite Point Capital Management added most to Tellurian Inc. in Q2 2018, an estimated $7.01M increase.
- Granite Point Capital Management's biggest Q2 2018 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $3.15M.
- Granite Point Capital Management fully exited Dine Brands in Q2 2018, selling an estimated $3.87M.
- Granite Point Capital Management's ten largest holdings make up 76% of its $1.12B portfolio in Q2 2018.
- Granite Point Capital Management opened 47 new positions and closed 36 in Q2 2018.
- Granite Point Capital Management's portfolio value rose 7.9% quarter-over-quarter to $1.12B.
Based on Granite Point Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.